speb/financial-data huggingface dataset:
VBF balance_sheet (quarterly, 2024-08-31) — Available For Sale Securities: 25539.00
VBF balance_sheet (quarterly, 2024-08-31) — Capital Stock: 219694983.00
VBF balance_sheet (quarterly, 2024-08-31) — Cash And Cash Equivalents: 4798.00
VBF balance_sheet (quarterly, 2024-08-31) — Cash Cash Equivalents And Federal Funds Sold: 4798.00
VBF balance_sheet (quarterly, 2024-08-31) — Cash Financial: 4798.00
VBF balance_sheet (quarterly, 2024-08-31) — Common Stock: 219694983.00
VBF balance_sheet (quarterly, 2024-08-31) — Common Stock Equity: 190369910.00
VBF balance_sheet (quarterly, 2024-08-31) — Derivative Product Liabilities: 778.00
VBF balance_sheet (quarterly, 2024-08-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 188098939.00
VBF balance_sheet (quarterly, 2024-08-31) — Investmentin Financial Assets: 188124478.00
VBF balance_sheet (quarterly, 2024-08-31) — Investments And Advances: 188124478.00
VBF balance_sheet (quarterly, 2024-08-31) — Net Tangible Assets: 190369910.00
VBF balance_sheet (quarterly, 2024-08-31) — Ordinary Shares Number: 11418446.00
VBF balance_sheet (quarterly, 2024-08-31) — Other Payable: 250704.00
VBF balance_sheet (quarterly, 2024-08-31) — Payables: 1260618.00
VBF balance_sheet (quarterly, 2024-08-31) — Receivables: 3686370.00
VBF balance_sheet (quarterly, 2024-08-31) — Retained Earnings: -29325073.00
VBF balance_sheet (quarterly, 2024-08-31) — Share Issued: 11418446.00
VBF balance_sheet (quarterly, 2024-08-31) — Stockholders Equity: 190369910.00
VBF balance_sheet (quarterly, 2024-08-31) — Tangible Book Value: 190369910.00
VBF balance_sheet (quarterly, 2024-08-31) — Total Assets: 191815646.00
VBF balance_sheet (quarterly, 2024-08-31) — Total Equity Gross Minority Interest: 190369910.00
VBF balance_sheet (quarterly, 2024-08-31) — Total Liabilities Net Minority Interest: 1445736.00
VBF income_statement (annual, 2025-02-28) — +Operating Expense: 373969.00
VBF income_statement (annual, 2025-02-28) — +Total Revenue: 13622729.00
VBF balance_sheet (annual, 2025-02-28) — Accounts Payable: 9305090.00
VBF balance_sheet (quarterly, 2025-02-28) — Accounts Payable: 9305090.00
VBF balance_sheet (annual, 2025-02-28) — Available For Sale Securities: 27392.00
VBF balance_sheet (quarterly, 2025-02-28) — Available For Sale Securities: 27392.00
VBF income_statement (annual, 2025-02-28) — Basic Average Shares: 11421345.00
VBF income_statement (annual, 2025-02-28) — Basic EPS: 1.16
VBF balance_sheet (annual, 2025-02-28) — Capital Stock: 219759218.00
VBF balance_sheet (quarterly, 2025-02-28) — Capital Stock: 219759218.00
VBF balance_sheet (annual, 2025-02-28) — Cash And Cash Equivalents: 107790.00
VBF balance_sheet (quarterly, 2025-02-28) — Cash And Cash Equivalents: 107790.00
VBF balance_sheet (annual, 2025-02-28) — Cash Cash Equivalents And Federal Funds Sold: 107790.00
VBF balance_sheet (quarterly, 2025-02-28) — Cash Cash Equivalents And Federal Funds Sold: 107790.00
VBF balance_sheet (annual, 2025-02-28) — Cash Financial: 107790.00
VBF balance_sheet (quarterly, 2025-02-28) — Cash Financial: 107790.00
VBF balance_sheet (annual, 2025-02-28) — Common Stock: 219759218.00
VBF balance_sheet (quarterly, 2025-02-28) — Common Stock: 219759218.00
VBF balance_sheet (annual, 2025-02-28) — Common Stock Equity: 187940024.00
VBF balance_sheet (quarterly, 2025-02-28) — Common Stock Equity: 187940024.00
VBF income_statement (annual, 2025-02-28) — Diluted Average Shares: 11421345.00
VBF income_statement (annual, 2025-02-28) — Diluted EPS: 1.16
VBF income_statement (annual, 2025-02-28) — Diluted NI Availto Com Stockholders: 13248760.00
VBF balance_sheet (annual, 2025-02-28) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 185826793.00
VBF balance_sheet (quarterly, 2025-02-28) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 185826793.00
VBF income_statement (annual, 2025-02-28) — Gain On Sale Of Security: -217132.00
VBF income_statement (annual, 2025-02-28) — General And Administrative Expense: 329195.00
VBF income_statement (annual, 2025-02-28) — Interest Income: 10406193.00
VBF balance_sheet (annual, 2025-02-28) — Investmentin Financial Assets: 185854724.00
VBF balance_sheet (quarterly, 2025-02-28) — Investmentin Financial Assets: 185854724.00
VBF balance_sheet (annual, 2025-02-28) — Investments And Advances: 185854724.00
VBF balance_sheet (quarterly, 2025-02-28) — Investments And Advances: 185854724.00
VBF income_statement (annual, 2025-02-28) — Net Income: 13248760.00
VBF income_statement (annual, 2025-02-28) — Net Income Common Stockholders: 13248760.00
VBF income_statement (annual, 2025-02-28) — Net Income Continuous Operations: 13248760.00
VBF income_statement (annual, 2025-02-28) — Net Income From Continuing And Discontinued Operation: 13248760.00
VBF income_statement (annual, 2025-02-28) — Net Income From Continuing Operation Net Minority Interest: 13248760.00
VBF income_statement (annual, 2025-02-28) — Net Income Including Noncontrolling Interests: 13248760.00
VBF income_statement (annual, 2025-02-28) — Net Interest Income: 10406193.00
VBF balance_sheet (annual, 2025-02-28) — Net Tangible Assets: 187940024.00
VBF balance_sheet (quarterly, 2025-02-28) — Net Tangible Assets: 187940024.00
VBF income_statement (annual, 2025-02-28) — Normalized Income: 13248760.00
VBF income_statement (annual, 2025-02-28) — Operating Revenue: 13622729.00
VBF balance_sheet (annual, 2025-02-28) — Ordinary Shares Number: 11425089.00
VBF balance_sheet (quarterly, 2025-02-28) — Ordinary Shares Number: 11425089.00
VBF income_statement (annual, 2025-02-28) — Other Operating Expenses: 44774.00
VBF balance_sheet (annual, 2025-02-28) — Other Payable: 228892.00
VBF balance_sheet (quarterly, 2025-02-28) — Other Payable: 228892.00
VBF balance_sheet (annual, 2025-02-28) — Payables: 9533982.00
VBF balance_sheet (quarterly, 2025-02-28) — Payables: 9533982.00
VBF income_statement (annual, 2025-02-28) — Pretax Income: 13248760.00
VBF balance_sheet (annual, 2025-02-28) — Receivables: 11643857.00
VBF balance_sheet (quarterly, 2025-02-28) — Receivables: 11643857.00
VBF balance_sheet (annual, 2025-02-28) — Retained Earnings: -31819194.00
VBF balance_sheet (quarterly, 2025-02-28) — Retained Earnings: -31819194.00
VBF income_statement (annual, 2025-02-28) — Selling General And Administration: 329195.00
VBF balance_sheet (annual, 2025-02-28) — Share Issued: 11425089.00
VBF balance_sheet (quarterly, 2025-02-28) — Share Issued: 11425089.00
VBF balance_sheet (annual, 2025-02-28) — Stockholders Equity: 187940024.00
VBF balance_sheet (quarterly, 2025-02-28) — Stockholders Equity: 187940024.00
VBF balance_sheet (annual, 2025-02-28) — Tangible Book Value: 187940024.00
VBF balance_sheet (quarterly, 2025-02-28) — Tangible Book Value: 187940024.00
VBF income_statement (annual, 2025-02-28) — Tax Effect Of Unusual Items: 0.00
VBF income_statement (annual, 2025-02-28) — Tax Rate For Calcs: 0.21
VBF balance_sheet (annual, 2025-02-28) — Total Assets: 197606870.00
VBF balance_sheet (quarterly, 2025-02-28) — Total Assets: 197606870.00
VBF balance_sheet (annual, 2025-02-28) — Total Equity Gross Minority Interest: 187940024.00
VBF balance_sheet (quarterly, 2025-02-28) — Total Equity Gross Minority Interest: 187940024.00
VBF balance_sheet (annual, 2025-02-28) — Total Liabilities Net Minority Interest: 9666846.00
VBF balance_sheet (quarterly, 2025-02-28) — Total Liabilities Net Minority Interest: 9666846.00
VBF balance_sheet (quarterly, 2025-08-31) — Accounts Payable: 1121621.00
VBF balance_sheet (quarterly, 2025-08-31) — Available For Sale Securities: 5953585.00
VBF balance_sheet (quarterly, 2025-08-31) — Capital Stock: 219759218.00
VBF balance_sheet (quarterly, 2025-08-31) — Cash And Cash Equivalents: 7819.00
VBF balance_sheet (quarterly, 2025-08-31) — Cash Cash Equivalents And Federal Funds Sold: 7819.00
VBF balance_sheet (quarterly, 2025-08-31) — Cash Financial: 7819.00
VBF balance_sheet (quarterly, 2025-08-31) — Common Stock: 219759218.00
VBF balance_sheet (quarterly, 2025-08-31) — Common Stock Equity: 187529134.00
VBF balance_sheet (quarterly, 2025-08-31) — Derivative Product Liabilities: 2178.00
VBF balance_sheet (quarterly, 2025-08-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 180071778.00
VBF balance_sheet (quarterly, 2025-08-31) — Investmentin Financial Assets: 186027309.00
VBF balance_sheet (quarterly, 2025-08-31) — Investments And Advances: 186027309.00
VBF balance_sheet (quarterly, 2025-08-31) — Net Tangible Assets: 187529134.00
VBF balance_sheet (quarterly, 2025-08-31) — Ordinary Shares Number: 11425089.00
VBF balance_sheet (quarterly, 2025-08-31) — Other Payable: 135387.00
VBF balance_sheet (quarterly, 2025-08-31) — Payables: 1257008.00
VBF balance_sheet (quarterly, 2025-08-31) — Receivables: 2855311.00
VBF balance_sheet (quarterly, 2025-08-31) — Retained Earnings: -32230084.00
VBF balance_sheet (quarterly, 2025-08-31) — Share Issued: 11425089.00
VBF balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 187529134.00
VBF balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 187529134.00
VBF balance_sheet (quarterly, 2025-08-31) — Total Assets: 188890439.00
VBF balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 187529134.00
VBF balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 1361305.00
VBF income_statement (annual, 2026-02-28) — +Operating Expense: 283684.00
VBF income_statement (annual, 2026-02-28) — +Total Revenue: 11889228.00
VBF balance_sheet (annual, 2026-02-28) — Accounts Payable: 8373050.00
VBF balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 8373050.00
VBF balance_sheet (annual, 2026-02-28) — Available For Sale Securities: 35640.00
VBF balance_sheet (quarterly, 2026-02-28) — Available For Sale Securities: 35640.00
VBF balance_sheet (annual, 2026-02-28) — Capital Stock: 219692244.00
VBF balance_sheet (quarterly, 2026-02-28) — Capital Stock: 219692244.00
VBF balance_sheet (annual, 2026-02-28) — Cash And Cash Equivalents: 160817.00
VBF balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 160817.00
VBF balance_sheet (annual, 2026-02-28) — Cash Cash Equivalents And Federal Funds Sold: 160817.00
VBF balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Federal Funds Sold: 160817.00
VBF balance_sheet (annual, 2026-02-28) — Cash Financial: 160817.00
VBF balance_sheet (quarterly, 2026-02-28) — Cash Financial: 160817.00
VBF balance_sheet (annual, 2026-02-28) — Common Stock: 219692244.00
VBF balance_sheet (quarterly, 2026-02-28) — Common Stock: 219692244.00
VBF balance_sheet (annual, 2026-02-28) — Common Stock Equity: 189971343.00
VBF balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 189971343.00
VBF balance_sheet (annual, 2026-02-28) — Derivative Product Liabilities: 2471.00
VBF balance_sheet (quarterly, 2026-02-28) — Derivative Product Liabilities: 2471.00
VBF income_statement (annual, 2026-02-28) — Diluted NI Availto Com Stockholders: 11605544.00
VBF balance_sheet (annual, 2026-02-28) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 188853197.00
VBF balance_sheet (quarterly, 2026-02-28) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 188853197.00
VBF income_statement (annual, 2026-02-28) — Gain On Sale Of Security: 786069.00
VBF income_statement (annual, 2026-02-28) — General And Administrative Expense: 242431.00
VBF income_statement (annual, 2026-02-28) — Interest Income: 10024741.00
VBF balance_sheet (annual, 2026-02-28) — Investmentin Financial Assets: 188983995.00
VBF balance_sheet (quarterly, 2026-02-28) — Investmentin Financial Assets: 188983995.00
VBF balance_sheet (annual, 2026-02-28) — Investments And Advances: 188983995.00
VBF balance_sheet (quarterly, 2026-02-28) — Investments And Advances: 188983995.00
VBF income_statement (annual, 2026-02-28) — Net Income: 11605544.00
VBF income_statement (annual, 2026-02-28) — Net Income Common Stockholders: 11605544.00
VBF income_statement (annual, 2026-02-28) — Net Income Continuous Operations: 11605544.00
VBF income_statement (annual, 2026-02-28) — Net Income From Continuing And Discontinued Operation: 11605544.00
VBF income_statement (annual, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: 11605544.00
VBF income_statement (annual, 2026-02-28) — Net Income Including Noncontrolling Interests: 11605544.00
VBF income_statement (annual, 2026-02-28) — Net Interest Income: 10024741.00
VBF balance_sheet (annual, 2026-02-28) — Net Tangible Assets: 189971343.00
VBF balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 189971343.00
VBF income_statement (annual, 2026-02-28) — Normalized Income: 11605544.00
VBF income_statement (annual, 2026-02-28) — Operating Revenue: 11889228.00
VBF balance_sheet (annual, 2026-02-28) — Ordinary Shares Number: 11425089.00
VBF balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 11425089.00
VBF income_statement (annual, 2026-02-28) — Other Operating Expenses: 41253.00
VBF balance_sheet (annual, 2026-02-28) — Other Payable: 369538.00
VBF balance_sheet (quarterly, 2026-02-28) — Other Payable: 369538.00
VBF balance_sheet (annual, 2026-02-28) — Payables: 8742588.00
VBF balance_sheet (quarterly, 2026-02-28) — Payables: 8742588.00
VBF income_statement (annual, 2026-02-28) — Pretax Income: 11605544.00
VBF balance_sheet (annual, 2026-02-28) — Receivables: 9740257.00
VBF balance_sheet (quarterly, 2026-02-28) — Receivables: 9740257.00
VBF balance_sheet (annual, 2026-02-28) — Retained Earnings: -29720901.00
VBF balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -29720901.00
VBF income_statement (annual, 2026-02-28) — Selling General And Administration: 242431.00
VBF balance_sheet (annual, 2026-02-28) — Share Issued: 11425089.00
VBF balance_sheet (quarterly, 2026-02-28) — Share Issued: 11425089.00
VBF balance_sheet (annual, 2026-02-28) — Stockholders Equity: 189971343.00
VBF balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 189971343.00
VBF balance_sheet (annual, 2026-02-28) — Tangible Book Value: 189971343.00
VBF balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 189971343.00
VBF income_statement (annual, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
VBF income_statement (annual, 2026-02-28) — Tax Rate For Calcs: 0.40
VBF balance_sheet (annual, 2026-02-28) — Total Assets: 198885379.00
VBF balance_sheet (quarterly, 2026-02-28) — Total Assets: 198885379.00
VBF balance_sheet (annual, 2026-02-28) — Total Equity Gross Minority Interest: 189971343.00
VBF balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 189971343.00
VBF balance_sheet (annual, 2026-02-28) — Total Liabilities Net Minority Interest: 8914036.00
VBF balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 8914036.00
VBIO balance_sheet (annual, 2021-12-31) — Accounts Receivable: 92000.00
VBIO balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -82000.00
VBIO balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 708000.00
VBIO cash_flow (annual, 2021-12-31) — Change In Inventory: -181000.00
VBIO cash_flow (annual, 2021-12-31) — Change In Receivables: -66000.00
VBIO cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -66000.00
VBIO income_statement (annual, 2021-12-31) — Cost Of Revenue: 1295000.00
VBIO balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 163000.00
VBIO balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 163000.00
VBIO balance_sheet (annual, 2021-12-31) — Current Deferred Assets: 0.00
VBIO balance_sheet (annual, 2021-12-31) — Finished Goods: 148000.00
VBIO cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -156000.00
VBIO income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 436000.00
VBIO balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 174000.00
VBIO income_statement (annual, 2021-12-31) — Gross Profit: -38000.00
VBIO cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 1000.00
VBIO income_statement (annual, 2021-12-31) — Interest Expense: 1823000.00
VBIO income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 1823000.00
VBIO cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 0.00
VBIO balance_sheet (annual, 2021-12-31) — Inventories Adjustments Allowances: 0.00
VBIO balance_sheet (annual, 2021-12-31) — Inventory: 429000.00
VBIO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 2613000.00
VBIO balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 545000.00
VBIO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 2613000.00
VBIO cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -19000.00
VBIO cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 2594000.00
VBIO cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 2594000.00
VBIO cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
VBIO cash_flow (annual, 2021-12-31) — Operating Gains Losses: 1323000.00
VBIO income_statement (annual, 2021-12-31) — Other Income Expense: -1038000.00
VBIO cash_flow (annual, 2021-12-31) — Other Non Cash Items: 1823000.00
VBIO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 162000.00
VBIO balance_sheet (annual, 2021-12-31) — Other Properties: 11000.00
VBIO income_statement (annual, 2021-12-31) — Other Special Charges: 1636000.00
VBIO balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
VBIO cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
VBIO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 834000.00
VBIO cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 58000.00
VBIO balance_sheet (annual, 2021-12-31) — Raw Materials: 281000.00
VBIO balance_sheet (annual, 2021-12-31) — Receivables: 92000.00
VBIO income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 1295000.00
VBIO cash_flow (annual, 2021-12-31) — Repayment Of Debt: -19000.00
VBIO income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 1787000.00
VBIO income_statement (annual, 2021-12-31) — Special Income Charges: -1636000.00
VBIO income_statement (annual, 2021-12-31) — Tax Provision: 1000.00
VBIO income_statement (annual, 2021-12-31) — Total Unusual Items: -1200000.00
VBIO income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -1200000.00
VBIO balance_sheet (annual, 2021-12-31) — Work In Process: 0.00
VBIO income_statement (annual, 2022-12-31) — +Operating Expense: 10397000.00
VBIO income_statement (annual, 2022-12-31) — +Total Revenue: 1840000.00
VBIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 1323000.00
VBIO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 107000.00
VBIO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -29000.00
VBIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 33272000.00
VBIO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
VBIO income_statement (annual, 2022-12-31) — Basic Average Shares: 5689.00
VBIO income_statement (annual, 2022-12-31) — Basic EPS: -1768.00
VBIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 12975000.00
VBIO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 523000.00
VBIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -11000.00
VBIO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 530000.00
VBIO balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3517000.00
VBIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 3517000.00
VBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -528000.00
VBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -11000.00
VBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -8919000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Account Payable: 534000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 109000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Inventory: -434000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 15000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -178000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Payable: 534000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 643000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 558000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Receivables: 1000.00
VBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: 605000.00
VBIO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 1000.00
VBIO cash_flow (annual, 2022-12-31) — Changes In Cash: -9458000.00
VBIO balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3630000.00
VBIO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
VBIO income_statement (annual, 2022-12-31) — Cost Of Revenue: 1541000.00
VBIO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 392000.00
VBIO balance_sheet (annual, 2022-12-31) — Current Assets: 5306000.00
VBIO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 163000.00
VBIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 163000.00
VBIO balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 584000.00
VBIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 1878000.00
VBIO cash_flow (annual, 2022-12-31) — Depreciation: 174000.00
VBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 174000.00
VBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 174000.00
VBIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 5689.00
VBIO income_statement (annual, 2022-12-31) — Diluted EPS: -1768.00
VBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -10096000.00
VBIO income_statement (annual, 2022-12-31) — EBIT: -10098000.00
VBIO income_statement (annual, 2022-12-31) — EBITDA: -9924000.00
VBIO cash_flow (annual, 2022-12-31) — End Cash Position: 3517000.00
VBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -528000.00
VBIO balance_sheet (annual, 2022-12-31) — Finished Goods: 116000.00
VBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: -8930000.00
VBIO income_statement (annual, 2022-12-31) — General And Administrative Expense: 5875000.00
VBIO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 88000.00
VBIO balance_sheet (annual, 2022-12-31) — Gross PPE: 564000.00
VBIO income_statement (annual, 2022-12-31) — Gross Profit: 299000.00
VBIO income_statement (annual, 2022-12-31) — Interest Income: 2000.00
VBIO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2000.00
VBIO balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Inventory: 863000.00
VBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 3630000.00
VBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -11000.00
VBIO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
VBIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 367000.00
VBIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 367000.00
VBIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
VBIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 11000.00
VBIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
VBIO income_statement (annual, 2022-12-31) — Net Income: -10096000.00
VBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -10096000.00
VBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -10096000.00
VBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -10096000.00
VBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -10096000.00
VBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -10096000.00
VBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -10096000.00
VBIO income_statement (annual, 2022-12-31) — Net Interest Income: 2000.00
VBIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
VBIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
VBIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 2000.00
VBIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -584000.00
VBIO balance_sheet (annual, 2022-12-31) — Net PPE: 535000.00
VBIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -11000.00
VBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3630000.00
VBIO income_statement (annual, 2022-12-31) — Normalized EBITDA: -9924000.00
VBIO income_statement (annual, 2022-12-31) — Normalized Income: -10096000.00
VBIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -8919000.00
VBIO income_statement (annual, 2022-12-31) — Operating Income: -10098000.00
VBIO income_statement (annual, 2022-12-31) — Operating Revenue: 1840000.00
VBIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 5692.00
VBIO balance_sheet (annual, 2022-12-31) — Other Current Assets: 235000.00
VBIO income_statement (annual, 2022-12-31) — Other Gand A: 5875000.00
VBIO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 34000.00
VBIO balance_sheet (annual, 2022-12-31) — Other Properties: 30000.00
VBIO balance_sheet (annual, 2022-12-31) — Payables: 1323000.00
VBIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1715000.00
VBIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
VBIO income_statement (annual, 2022-12-31) — Pretax Income: -10096000.00
VBIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 56000.00
VBIO balance_sheet (annual, 2022-12-31) — Properties: 0.00
VBIO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
VBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -11000.00
VBIO balance_sheet (annual, 2022-12-31) — Raw Materials: 724000.00
VBIO balance_sheet (annual, 2022-12-31) — Receivables: 107000.00
VBIO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1541000.00
VBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 174000.00
VBIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
VBIO income_statement (annual, 2022-12-31) — Research And Development: 1730000.00
VBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: -29642000.00
VBIO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 2792000.00
VBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 8667000.00
VBIO balance_sheet (annual, 2022-12-31) — Share Issued: 5692.00
VBIO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
VBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 398000.00
VBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3630000.00
VBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3630000.00
VBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
VBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Total Assets: 5875000.00
VBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 3630000.00
VBIO balance_sheet (annual, 2022-12-31) — Total Debt: 530000.00
VBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3630000.00
VBIO income_statement (annual, 2022-12-31) — Total Expenses: 11938000.00
VBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2245000.00
VBIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 569000.00
VBIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 367000.00
VBIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -10098000.00
VBIO income_statement (annual, 2022-12-31) — Total Other Finance Cost: -2000.00
VBIO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
VBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
VBIO balance_sheet (annual, 2022-12-31) — Work In Process: 23000.00
VBIO balance_sheet (annual, 2022-12-31) — Working Capital: 3428000.00
VBIO income_statement (annual, 2023-12-31) — +Operating Expense: 8532000.00
VBIO income_statement (annual, 2023-12-31) — +Total Revenue: 1176000.00
VBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 713000.00
VBIO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 174000.00
VBIO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -37000.00
VBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 41466000.00
VBIO income_statement (annual, 2023-12-31) — Basic Average Shares: 46650.00
VBIO income_statement (annual, 2023-12-31) — Basic EPS: -176.80
VBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3517000.00
VBIO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 349000.00
VBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -118000.00
VBIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 369000.00
VBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3395000.00
VBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 3395000.00
VBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 8507000.00
VBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -118000.00
VBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -8511000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Account Payable: -610000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 103000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Inventory: 75000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
VBIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -161000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Payable: -610000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -507000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -92000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Receivables: -67000.00
VBIO cash_flow (annual, 2023-12-31) — Change In Working Capital: -752000.00
VBIO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -67000.00
VBIO cash_flow (annual, 2023-12-31) — Changes In Cash: -122000.00
VBIO balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3580000.00
VBIO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 8507000.00
VBIO income_statement (annual, 2023-12-31) — Cost Of Revenue: 889000.00
VBIO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 335000.00
VBIO balance_sheet (annual, 2023-12-31) — Current Assets: 4652000.00
VBIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 193000.00
VBIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 193000.00
VBIO balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 1401000.00
VBIO cash_flow (annual, 2023-12-31) — Depreciation: 182000.00
VBIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 182000.00
VBIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 182000.00
VBIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 46650.00
VBIO income_statement (annual, 2023-12-31) — Diluted EPS: -176.80
VBIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -8244000.00
VBIO income_statement (annual, 2023-12-31) — EBIT: -8245000.00
VBIO income_statement (annual, 2023-12-31) — EBITDA: -8063000.00
VBIO cash_flow (annual, 2023-12-31) — End Cash Position: 3395000.00
VBIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 8507000.00
VBIO balance_sheet (annual, 2023-12-31) — Finished Goods: 36000.00
VBIO cash_flow (annual, 2023-12-31) — Free Cash Flow: -8629000.00
VBIO income_statement (annual, 2023-12-31) — General And Administrative Expense: 4752000.00
VBIO balance_sheet (annual, 2023-12-31) — Gross PPE: 508000.00
VBIO income_statement (annual, 2023-12-31) — Gross Profit: 287000.00
VBIO income_statement (annual, 2023-12-31) — Interest Income: 1000.00
VBIO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1000.00
VBIO balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -32000.00
VBIO balance_sheet (annual, 2023-12-31) — Inventory: 756000.00
VBIO balance_sheet (annual, 2023-12-31) — Invested Capital: 3580000.00
VBIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -118000.00
VBIO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 8507000.00
VBIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 176000.00
VBIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 176000.00
VBIO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 11000.00
VBIO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 8507000.00
VBIO income_statement (annual, 2023-12-31) — Net Income: -8244000.00
VBIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -8244000.00
VBIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8244000.00
VBIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -8244000.00
VBIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -8244000.00
VBIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8244000.00
VBIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8244000.00
VBIO income_statement (annual, 2023-12-31) — Net Interest Income: 1000.00
VBIO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1000.00
VBIO balance_sheet (annual, 2023-12-31) — Net PPE: 471000.00
VBIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -118000.00
VBIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3580000.00
VBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
VBIO income_statement (annual, 2023-12-31) — Normalized EBITDA: -8063000.00
VBIO income_statement (annual, 2023-12-31) — Normalized Income: -8244000.00
VBIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -8511000.00
VBIO income_statement (annual, 2023-12-31) — Operating Income: -8245000.00
VBIO income_statement (annual, 2023-12-31) — Operating Revenue: 1176000.00
VBIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 86240.00
VBIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 327000.00
VBIO income_statement (annual, 2023-12-31) — Other Gand A: 4752000.00
VBIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 34000.00
VBIO balance_sheet (annual, 2023-12-31) — Other Properties: 148000.00
VBIO balance_sheet (annual, 2023-12-31) — Payables: 873000.00
VBIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1208000.00
VBIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
VBIO income_statement (annual, 2023-12-31) — Pretax Income: -8244000.00
VBIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Properties: 0.00
VBIO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 32000.00
VBIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -118000.00
VBIO balance_sheet (annual, 2023-12-31) — Raw Materials: 752000.00
VBIO balance_sheet (annual, 2023-12-31) — Receivables: 174000.00
VBIO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 889000.00
VBIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 182000.00
VBIO income_statement (annual, 2023-12-31) — Research And Development: 1655000.00
VBIO balance_sheet (annual, 2023-12-31) — Retained Earnings: -37886000.00
VBIO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 2125000.00
VBIO income_statement (annual, 2023-12-31) — Selling General And Administration: 6877000.00
VBIO balance_sheet (annual, 2023-12-31) — Share Issued: 86240.00
VBIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 271000.00
VBIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3580000.00
VBIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3580000.00
VBIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
VBIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Total Assets: 5157000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Capitalization: 3580000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Debt: 369000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3580000.00
VBIO income_statement (annual, 2023-12-31) — Total Expenses: 9421000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1577000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 505000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 176000.00
VBIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -8245000.00
VBIO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 160000.00
VBIO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Work In Process: 0.00
VBIO balance_sheet (annual, 2023-12-31) — Working Capital: 3251000.00
VBIO balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 9000.00
VBIO balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: 0.00
VBIO cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
VBIO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 364184.00
VBIO income_statement (quarterly, 2024-09-30) — Basic EPS: -3.93
VBIO balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 0.00
VBIO cash_flow (quarterly, 2024-09-30) — Change In Receivables: 7000.00
VBIO cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 7000.00
VBIO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 15000.00
VBIO income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 82000.00
VBIO balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 0.00
VBIO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 364184.00
VBIO income_statement (quarterly, 2024-09-30) — Diluted EPS: -3.93
VBIO balance_sheet (quarterly, 2024-09-30) — Finished Goods: 245000.00
VBIO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 9000.00
VBIO income_statement (quarterly, 2024-09-30) — Gross Profit: 44000.00
VBIO balance_sheet (quarterly, 2024-09-30) — Inventories Adjustments Allowances: 0.00
VBIO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 15000.00
VBIO balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
VBIO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 15000.00
VBIO cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Other Properties: 148000.00
VBIO income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
VBIO cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
VBIO cash_flow (quarterly, 2024-09-30) — Provisionand Write Offof Assets: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Raw Materials: 481000.00
VBIO balance_sheet (quarterly, 2024-09-30) — Receivables: 9000.00
VBIO income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 82000.00
VBIO income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 234000.00
VBIO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Total Debt: 0.00
VBIO income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
VBIO income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
VBIO balance_sheet (quarterly, 2024-09-30) — Work In Process: 5000.00
VBIO income_statement (annual, 2024-12-31) — +Operating Expense: 4476000.00
VBIO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 125000.00
VBIO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 69000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 69000.00
VBIO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -40000.00
VBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 46075000.00
VBIO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 397000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 397000.00
VBIO income_statement (annual, 2024-12-31) — Basic Average Shares: 287370.00
VBIO income_statement (annual, 2024-12-31) — Basic EPS: -19.68
VBIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3395000.00
VBIO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 1000.00
VBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2002000.00
VBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2002000.00
VBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 4332000.00
VBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
VBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -5082000.00
VBIO cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -643000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Account Payable: -588000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -348000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Inventory: 83000.00
VBIO cash_flow (quarterly, 2024-12-31) — Change In Inventory: 74000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 34000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -369000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Payable: -588000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -936000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 78000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Receivables: 105000.00
VBIO cash_flow (quarterly, 2024-12-31) — Change In Receivables: -55000.00
VBIO cash_flow (annual, 2024-12-31) — Change In Working Capital: -1193000.00
VBIO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 105000.00
VBIO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -55000.00
VBIO cash_flow (annual, 2024-12-31) — Changes In Cash: -1393000.00
VBIO balance_sheet (annual, 2024-12-31) — Common Stock: 1000.00
VBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2535000.00
VBIO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 4381000.00
VBIO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 1115000.00
VBIO income_statement (annual, 2024-12-31) — Cost Of Revenue: 778000.00
VBIO income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 419000.00
VBIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 132000.00
VBIO balance_sheet (annual, 2024-12-31) — Current Assets: 2639000.00
VBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 272000.00
VBIO cash_flow (annual, 2024-12-31) — Depreciation: 352000.00
VBIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 352000.00
VBIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 352000.00
VBIO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
VBIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 287370.00
VBIO income_statement (annual, 2024-12-31) — Diluted EPS: -19.68
VBIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -5655000.00
VBIO income_statement (annual, 2024-12-31) — EBIT: -4470000.00
VBIO income_statement (annual, 2024-12-31) — EBITDA: -4118000.00
VBIO cash_flow (annual, 2024-12-31) — End Cash Position: 2002000.00
VBIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 4332000.00
VBIO balance_sheet (annual, 2024-12-31) — Finished Goods: 192000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Finished Goods: 192000.00
VBIO cash_flow (annual, 2024-12-31) — Free Cash Flow: -5725000.00
VBIO income_statement (annual, 2024-12-31) — General And Administrative Expense: 3163000.00
VBIO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 42000.00
VBIO income_statement (annual, 2024-12-31) — Gross Profit: 2000.00
VBIO income_statement (quarterly, 2024-12-31) — Gross Profit: -239000.00
VBIO income_statement (annual, 2024-12-31) — Interest Expense: 0.00
VBIO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
VBIO income_statement (annual, 2024-12-31) — Interest Income: 6000.00
VBIO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 6000.00
VBIO balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -338000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -338000.00
VBIO balance_sheet (annual, 2024-12-31) — Inventory: 319000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Inventory: 319000.00
VBIO balance_sheet (annual, 2024-12-31) — Invested Capital: 2535000.00
VBIO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
VBIO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 4381000.00
VBIO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 1115000.00
VBIO balance_sheet (annual, 2024-12-31) — Liabilities Heldfor Sale Non Current: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Liabilities Heldfor Sale Non Current: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 11000.00
VBIO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 4381000.00
VBIO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 1115000.00
VBIO income_statement (annual, 2024-12-31) — Net Income: -5655000.00
VBIO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -5655000.00
VBIO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -4470000.00
VBIO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -1185000.00
VBIO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -5655000.00
VBIO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4470000.00
VBIO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -4470000.00